Delisting risk
Oragenics (OGEN)
Developing an intranasal concussion treatment candidate through outsourced clinical development.
$0.4998
Pre-market−0.02 (−4.62%)
At close$0.5240(+5.01%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions20 holders · as of Mar 31, 2026 | 4.22% | 190.4K shares | |
| Strategic holders1 holder · as of Jan 21, 2026 | 9.15% | 412.7K shares | |
| Otherremainder | 86.63% | 3.91M shares |
4.51M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
20 holders · 190.4K shares · 12 new positions · 14 increased · 1 reduced · 8 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 65.1K | 1.44% | +65.1Knew | May 15, 2026 |
| Pathstone Holdings, LLC | 55.0K | 1.22% | +55.0Knew | May 11, 2026 |
| Two Sigma Securities, LLC | 20.3K | 0.45% | +20.3Knew | May 15, 2026 |
| HRT Financial LP | 18.7K | 0.41% | +18.7Knew | May 14, 2026 |
| Virtu Financial LLC | 17.6K | 0.39% | +17.6Knew | May 14, 2026 |
| UBS Group AG | 5.2K | 0.12% | +2.8K | May 5, 2026 |
| Tower Research Capital LLC (TRC) | 4.5K | 0.10% | −5 | May 15, 2026 |
| Ameritas Advisory Services, LLC | 2.0K | 0.04% | +2.0Knew | May 12, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Five Narrow Lane LP | 9.99% | 82.2K | 13G | Jul 2, 2025 ↗ |
| Sabby Management, LLC | 9.90% | 412.7K | 13G | Jan 21, 2026 ↗ |
Insider tradesForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.